iShares Biotechnology ETF Rating $139.64 +0.57 (+0.41%) As of 11:47 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestTrendsBuy This Stock iShares Biotechnology ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBB Aggregate RatingModerate Buy 2.70Holdings in IBB have an aggregate rating of Moderate Buy based on 478 analyst ratings issued in the past year covering 25 companies (69.1% of the portfolio).IBB Aggregate Price Target$139.41-0.17% DownsideHigh Prediction$139.41Average Prediction$139.41Low Prediction$139.41Holdings in IBB have an aggregate price target of $139.41 and a range of $139.41 to $139.41 covering 25 companies (69.1% of the portfolio).IBB Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy15 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 IBB Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings7.20%GILDGilead Sciences$110.960.0%4.9461 of 5 stars2.89$117.17 5.6%28Positive NewsAnalyst Revision6.68%AMGNAmgen$270.94-0.1%4.7772 of 5 stars2.30$309.70 14.3%20Positive NewsAnalyst Forecast6.22%VRTXVertex Pharmaceuticals$384.16+0.6%4.9141 of 5 stars2.68$493.81 28.5%28Trending NewsAnalyst UpgradeAnalyst Revision6.21%REGNRegeneron Pharmaceuticals$555.70+0.0%4.7526 of 5 stars2.82$817.67 47.1%28Positive News6.19%ALNYAlnylam Pharmaceuticals$444.50-1.1%3.6231 of 5 stars2.86$439.58 -1.1%283.42%IQVIQVIA$178.31+0.9%4.9578 of 5 stars2.75$229.64 28.8%24Positive News3.21%INSMInsmed$135.34-0.2%3.3219 of 5 stars2.94$139.86 3.3%17Positive News3.10%ARGXargenex$718.15+1.0%4.1235 of 5 stars3.08$789.20 9.9%242.78%MTDMettler-Toledo International$1,217.34+0.6%4.2107 of 5 stars2.50$1,325.56 8.9%10Positive News2.32%NTRANatera$160.88-1.7%3.6328 of 5 stars3.00$192.88 19.9%19Positive News2.26%BIIBBiogen$137.42+1.3%4.6587 of 5 stars2.35$182.04 32.5%31Analyst Forecast1.93%ONCBeOne Medicines$325.78-0.9%1.8018 of 5 stars3.11$336.30 3.2%91.90%UTHRUnited Therapeutics$428.37+0.7%4.5784 of 5 stars2.71$448.14 4.6%14Analyst ForecastInsider Trade1.87%WATWaters$291.01+1.1%4.7539 of 5 stars2.47$378.73 30.1%15Trending News1.69%INCYIncyte$82.19+0.7%4.7452 of 5 stars2.33$83.67 1.8%18Analyst Forecast1.56%ILMNIllumina$91.87-0.3%4.8224 of 5 stars2.21$123.06 33.9%19Positive News1.54%BNTXBioNTech$97.25-0.8%2.642 of 5 stars2.79$134.56 38.4%141.44%NBIXNeurocrine Biosciences$140.37-0.4%4.4233 of 5 stars2.85$161.89 15.3%201.22%MEDPMedpace$491.36+0.7%4.1157 of 5 stars1.94$422.27 -14.1%171.20%GMABGenmab A/S$28.87+0.1%3.6736 of 5 stars2.73$40.00 38.6%11Analyst Upgrade1.10%EXELExelixis$38.93+0.6%4.6949 of 5 stars2.61$44.42 14.1%23Positive News1.09%BMRNBioMarin Pharmaceutical$53.17+1.1%4.9432 of 5 stars2.64$92.60 74.1%22Positive News1.04%IONSIonis Pharmaceuticals$63.85+1.4%3.9464 of 5 stars2.88$73.88 15.7%17Trending NewsAnalyst ForecastAnalyst Revision1.00%HALOHalozyme Therapeutics$74.32+0.5%4.4921 of 5 stars2.42$69.89 -6.0%12Analyst ForecastInsider Trade0.92%MDGLMadrigal Pharmaceuticals$423.46+0.1%4.0722 of 5 stars2.90$483.38 14.1%10Positive News This page (NASDAQ:IBB) was last updated on 9/26/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredNew Buy Alert: Should you put $1,000 into Oracle (ORCL) now?Barron's is calling this Oracle's "Nvidia Moment..." While the Wall Street Journal is simply calling Oracle...Chaikin Analytics | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredShots officially fired…Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the righ...Brownstone Research | SponsoredAnother gold high? Here’s the move Wall Street is missing …Gold has surged past $3,600 an ounce, up 45% in the last year, but Weiss Ratings analyst Sean Brodrick says th...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IBB Stock Alerts